ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,922Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 189

$603K Total Retail Price of All Prescriptions

Rank: 10 out of 189

542 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 7,835 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 503 406 1 4
LISINOPRIL 478 378 2 1
OMEPRAZOLE 434 266 3 3
SIMVASTATIN 398 290 4 2
ATENOLOL 300 232 5 12
METOPROLOL TARTRATE 290 227 6 6
LEVOTHYROXINE SODIUM 268 193 7 5
FUROSEMIDE 243 202 8 10
ATORVASTATIN CALCIUM 213 181 9 9
HYDROCODONE-ACETAMINOPHEN 191 121 S3 10 11
METFORMIN HCL ER 175 113 11 37
ZOLPIDEM TARTRATE 168 127 12 24
PRAVASTATIN SODIUM 163 118 13 13
GABAPENTIN 154 122 14 22
SERTRALINE HCL 136 115 15 17
HYDROCHLOROTHIAZIDE 131 118 16 8
IBUPROFEN 125 39 17 34
LOSARTAN POTASSIUM 123 111 18 20
TRAMADOL HCL 121 66 19 32
WARFARIN SODIUM 118 115 20 14
CLOPIDOGREL 116 96 21 48
GLIPIZIDE 115 84 22 39
CITALOPRAM HBR 112 88 23 15
CARVEDILOL 102 73 24 65
ALENDRONATE SODIUM 101 92 25 18
TRAZODONE HCL 98 62 26 16
PREDNISONE 96 52 27 38
PAROXETINE HCL 95 76 28 46
METFORMIN HCL 92 64 29 7
ISOSORBIDE MONONITRATE ER 85 76 30 85
GLIMEPIRIDE 83 69 31 71
SPIRIVA 80 50 32 33
PLAVIX 79 69 33 74
CYCLOBENZAPRINE HCL 79 33 R 33 90
FENOFIBRATE 75 42 35 36
CRESTOR 73 35 36 31
MELOXICAM 72 60 37 54
CIPROFLOXACIN HCL 71 52 38 69
ALLOPURINOL 69 65 39 25
RANITIDINE HCL 69 41 39 26
QUINAPRIL HCL 69 59 39 53
LOVAZA 61 25 42 162
PANTOPRAZOLE SODIUM 60 28 43 58
KLOR-CON 10 59 50 44 105
METOPROLOL SUCCINATE 58 58 45 19
MECLIZINE HCL 57 45 46 114
AMLODIPINE BESYLATE-BENAZEPRIL 56 42 47 91
LOSARTAN-HYDROCHLOROTHIAZIDE 55 44 48 43
COMBIVENT 55 14 48 116
FLUTICASONE PROPIONATE 53 32 50 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.